Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-22

Clinical Trial Update: Efficacy of Suvorexant on Post-operative Sleep Disturbance [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating suvorexant for postoperative sleep disturbances, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belsomra (suvorexant)

Snippet

Sponsor: Columbia University | Conditions: Postoperative Insomnia, Postoperative Delirium | Phase 4 | Status: RECRUITING